ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CRYO Cryo-Save

420.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cryo-Save CRYO London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 420.00 00:00:00
Open Price Low Price High Price Close Price Previous Close
420.00 420.00
more quote information »

Cryo-Save CRYO Dividends History

No dividends issued between 29 Mar 2014 and 29 Mar 2024

Top Dividend Posts

Top Posts
Posted at 31/3/2011 08:29 by dannys
cryo offers to store stem cells for japan..........
Posted at 26/8/2010 15:37 by dannys
still here! thought some kind of news would be announced by now but still holding on for the long term with this one.......
cant seem to find any other boards that discuss cryo, must admit it gets boring just holding on and waiting but sure it will be worth it in the long term..well hope so!
Posted at 02/8/2010 12:03 by dannys
hi eater24, sitting on a good few of these bought at low price long ago and happy to hold, thinking about adding more as am sure these have great potential!

any other boards that discuss cryo you know of?
Posted at 30/6/2010 16:32 by dannys
price up on euronext.........

anyone know how to go about selling shares in cryo now they have delisted?

still holding via the crest system but not sure how to go about selling when the time comes as my broker says they do not trade euronext.
Posted at 26/3/2010 08:37 by ygor705
The share price is obviously being more influenced by the AIM delisting than the results and prospects at the moment. The only thing that surprises me is that there is not enough demand in Amsterdam to mop up London sales. Are the Dutch too busy planting tulips? Has Cryo made the right decision? The UK MMs will undoubtedly push stock through to Euronext if there is money to be made. Monitoring the Euronext Cryo share price would seem sensible to me.
Posted at 01/3/2010 13:39 by masurenguy
Interesting article - thanks for the link dannys. A couple of points caught my eye.

"The world market for stem cell therapy is projected to increase from an estimated $30bn in 2009 to $96bn by 2015. The US President Barack Obama recently lifted an eight-year-old ban on government-supported funding for embryonic stem cell research, opening floodgates for huge investments in the sector".

This projects an annual CAGR of 21% with the global market more than trebling in size over the next 6 years. That has got to be good news for Cryo-Save who are the established market leader.

"In India, the industry put together has banked around 25,000 cord blood units over the last three years".

The aggregate volume for the whole Indian market in stem cell storage over the past 3 years (25,000) is still far less than the Cryo-Saves overall international volume just last year (2009 volume 27,900). That puts their current market position into proper perspective and they are also well positioned to develop sales in the growing Indian market through their wholly owned subsidary there.
Posted at 07/1/2010 07:16 by masurenguy
RNS Number : 1518F
Cryo-Save Group NV
07 January 2010

New storage record, over 7,300 samples stored in Q4 2009 - up 18% on Q4 2008

Cryo-Save Group N.V. (AIM/Euronext: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, stored over 7,300 samples in Q4 2009, up 18% over Q4 2008 (6,200 samples). This is the highest quarterly storage volume to date for the Group. The total number of samples stored for the whole of 2009 increased by 11% to 27,900 (2008: 25,200). The Group now stores in total over 120,000 samples.

In Q4 2009, 1,300 customers opted to take up the Group's additional service to store stem cells from the umbilical cord itself, as well as from the cord blood, bringing the total number of cord samples to 3,800. The Group expects to publish its results for the year to 31 December 2009 during the week commencing 22 March 2010.

Marc Waeterschoot, Chief Executive, commented: "Despite difficult economic circumstances, the Group's double digit year on year growth for 2009 is very positive, and has been driven by the significant growth we have seen in Spain, Italy, Serbia and India. With our leading international position, the further roll out of the umbilical cord service, combined with our profitability and healthy cash position, we are confident of maintaining our momentum in 2010."
Posted at 08/10/2009 06:21 by masurenguy
RNS Number : 4183A
Cryo-Save Group NV
08 October 2009

Share Consolidation

Cryo-Save Group N.V. (AIM: CRYO, 'Cryo-Save' or 'the Company'), Europe's leading stem cell bank, confirms that pursuant to the passing of the relevant resolutions at an EGM of the Company held on 5 October 2009, and as notified on that day, the proposed 5:1 share consolidation has this morning become effective. As result of the share consolidation the Company's authorised share capital now comprises 9,639,191 ordinary shares of €0.10 each; the associated depository interests for these ordinary shares will commence trading at 8:00am today under ISIN NL0009272137.

About Cryo-Save

With more than 115,000 samples saved, Cryo-Save is the leading stem cell bank in Europe and one of the fastest growing in the world. Driven by its international business strategy, Cryo-Save is now represented in 38 countries on three continents and has state-of-the-art processing facilities in Belgium, Germany, Dubai, India and France (under construction). Cryo-Save sets the highest quality standards in stem cell storage, as it aims to make an important contribution to conquer possible life-threatening diseases in the future. As a service to the public, Cryo-Save offers a Cost-free Family Donation Programme, free of charge, to families wishing to store their newborn's umbilical cord blood stem cells for a family member diagnosed with a life-threatening disease treatable by stem cells. The company is committed to further improve stem cell cryopreservation techniques, by participating in European Commission funded projects, in Universities and Hospitals.
Posted at 12/9/2009 13:21 by masurenguy
Some positive news prior to the interim results on Tuesday.

Cryo-Save India gets ISO 9001:2008 certification

Bangalore, Sep 10, 2009: Cryo–Save India, a part of Cryo-Save Group, Europe's largest adult stem cell storage bank, achieved a significant milestone with TUV Rheinland, Germany, conferring the India operations an ISO 9001:2008 certification. TUV Rheinland, a leading quality management systems registrar from Germany, certified Cryo-Save India after examining the lab on various parameters.

Cryo-Save India is dedicated to the highest quality standards and is the only company in its category to have received ISO 9001:2008 certification from TUV Rheinland, within such a short duration since commencement of its operations. The certification from TUV Rheinland helps to strengthen the processes and systems employed by Cryo-Save India, which include fully-automated systems that ensure no human intervention in storage and retrieval process along with a unique dual storage process.

"With years of delivering leading-edge solutions in the sphere of adult stem cell banking, Cryo-Save India has always been stringent on quality, thus taking the promise of uncompromised quality to its discerning customers. This certification strengthens our core proposition of delivering global standards through our processes and systems," said Mr Chandramouli, Managing Director, Cryo Save India.

As part of the ISO 9001 process, TUV performed on-site assessments, examining the Cryo-Save India documention procedures and audited its overall operations. To determine continued compliance with ISO 9001:2008, TUV would conduct periodically scheduled audits at Cryo–Save India and examine and monitor its business operations. Quality Council of India, the authority in India for ISO-related standards, too can conduct random audits to verify organization's compliance to declared practices.
Posted at 03/9/2009 09:19 by masurenguy
Interesting development which indicates the extent of their ambitions. Euronext is the largest stock exchange in Europe who subsequently merged with the NYSE just under two years ago to form part of the largest stock market in the world. A Euronext listing will provide them with international exposure to investors and should enhance the credibility of their future expansion plans.

RNS Number : 4504Y
Cryo-Save Group NV
03 September 2009

Cryo-Save plans to list on Euronext

Cryo-Save Group N.V. (AIM: CRYO, "Cryo-Save"), Europe's leading stem cell
bank, plans to seek an additional listing on Euronext Amsterdam in the fourth
quarter of the current financial year to complement the Group's shares being
traded on AIM in London. Cryo-Save was admitted to trading on AIM on 6 November 2007.

Cryo-Save intends to review the need to maintain the AIM listing early
2010. Cryo-Save expects to make further announcements with regards to the
Euronext listing in due course.

Marc Waeterschoot, Chief Executive, commented: "We are looking to become listed on Euronext in Amsterdam. Being a Dutch company, with most of our business on the continent, a local listing should increase our visibility as well as liquidity."

Your Recent History

Delayed Upgrade Clock